US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Ongoing

Desferal 2.5 gm/14 mL Sterile Water

Reason Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.

Franck's Lab Inc dba Trinity Care Solutions D-1456-2014
Class II · Moderate risk Ongoing

Pfizerpen

Reason Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.

Franck's Lab Inc dba Trinity Care Solutions D-1455-2014
Class II · Moderate risk Ongoing

Vancomycin 750 mg/100 mL 0.9%NS

Reason Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.

Franck's Lab Inc dba Trinity Care Solutions D-1454-2014
Class II · Moderate risk Ongoing

Levofloxacin 750 mg/250 mL D5W

Reason Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.

Franck's Lab Inc dba Trinity Care Solutions D-1453-2014
Class II · Moderate risk Ongoing

Yohimbine 10 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-796-2013
Class II · Moderate risk Ongoing

Xylazine 300 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-795-2013
Class II · Moderate risk Ongoing

Vitamin B-Buildup Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-793-2013
Class II · Moderate risk Ongoing

Vitamin B12 Cyanocobalamin 5000 mcg Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-792-2013
Class II · Moderate risk Ongoing

Vitamin B12

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-791-2013
Class II · Moderate risk Ongoing

Vitamin A/D3/E Olive Oil Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-790-2013
Class II · Moderate risk Ongoing

Vitamin 15

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-789-2013
Class II · Moderate risk Ongoing

Tripelennamine 20 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-788-2013
Class II · Moderate risk Ongoing

Trimix

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-787-2013
Class II · Moderate risk Ongoing

Testosterone Cypionate

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-786-2013
Class II · Moderate risk Ongoing

Taurine 100 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-785-2013
Class II · Moderate risk Ongoing

Tacrolimus

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-784-2013
Class II · Moderate risk Ongoing

Stanozolol

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-783-2013
Class II · Moderate risk Ongoing

Sodium Tetradecyl Sulfate

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-782-2013
Class II · Moderate risk Ongoing

Sodium Salicylate 40% Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-781-2013
Class II · Moderate risk Ongoing

Sodium Iodide 20% Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-780-2013
Class II · Moderate risk Ongoing

Sermorelin/GHRP 3 mg/3 mg vial

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-779-2013
Class II · Moderate risk Ongoing

Quadmix

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-778-2013
Class II · Moderate risk Ongoing

Progesterone EO 100 mg/ml Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-777-2013
Class II · Moderate risk Ongoing

Progesterone 100 mg/ml in Olive Oil Injection

Reason Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Lowlite Investments, Inc. D/B/A Olympia Pharmacy D-776-2013